Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

454 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
(E)-N'-(1-(7-Hydroxy-2-Oxo-2H-Chromen-3-Yl) Ethylidene) Benzohydrazide, a Novel Synthesized Coumarin, Ameliorates Isoproterenol-Induced Myocardial Infarction in Rats through Attenuating Oxidative Stress, Inflammation, and Apoptosis.
Feriani A, Khdhiri E, Tir M, Elmufti A, Tlili N, Hajji R, Ammar H, Allouche N, Abid S, Ghazouani L, Mnafgui K. Feriani A, et al. Among authors: abid s. Oxid Med Cell Longev. 2020 Mar 6;2020:2432918. doi: 10.1155/2020/2432918. eCollection 2020. Oxid Med Cell Longev. 2020. PMID: 32215169 Free PMC article.
(E)-N'-(1-(3-oxo-3H-benzo[f]chromen-2-yl)ethylidene)benzohydrazide protecting rat heart tissues from isoproterenol toxicity: Evidence from in vitro and in vivo tests.
Khdhiri E, Mnafgui K, Ghazouani L, Feriani A, Hajji R, Bouzanna W, Allouche N, Bazureau JP, Ammar H, Abid S. Khdhiri E, et al. Among authors: abid s. Eur J Pharmacol. 2020 Aug 15;881:173137. doi: 10.1016/j.ejphar.2020.173137. Epub 2020 May 4. Eur J Pharmacol. 2020. PMID: 32380016 Free article.
Cardioprotective effects of (E)-4-hydroxy-N'-(1-(3-oxo-3H-benzo[f]chromen-2-yl)ethylidene)benzohydrazide: a newly synthesized coumarin hydrazone against isoproterenol-induced myocardial infarction in a rat model.
Ghazouani L, Khdhiri E, Elmufti A, Feriani A, Tir M, Baaziz I, Hajji R, Ben Mansour H, Ammar H, Abid S, Mnafgui K. Ghazouani L, et al. Among authors: abid s. Can J Physiol Pharmacol. 2019 Oct;97(10):989-998. doi: 10.1139/cjpp-2019-0085. Epub 2019 Aug 29. Can J Physiol Pharmacol. 2019. PMID: 31464528
Anti-embolic and anti-oxidative effects of a novel (E)-4-amino-N'-(1-(7-hydroxy-2-oxo-2H-chromen-3-yl) ethylidene) benzohydrazide against isoproterenol and vitamin-K induced ischemic stroke.
Mnafgui K, Khdhiri E, Ghazouani L, Ncir M, Zaafouri Z, Allouche N, Elfeki A, Ammar H, Abid S, Hajji R. Mnafgui K, et al. Among authors: abid s. Arch Physiol Biochem. 2021 Dec;127(6):527-540. doi: 10.1080/13813455.2019.1657900. Epub 2019 Aug 30. Arch Physiol Biochem. 2021. PMID: 31469295
Potential effect of new (E)-4-hydroxy -N'-(1-(7-hydroxy-2-oxo-2H-chromen-3-yl) ethylidene) benzohydrazide against acute myocardial infarction: Haemodynamic, biochemical and histological studies.
Mnafgui K, Khdhiri E, Hajji R, Feriani A, Ivan da Silva F, Laíres da Silva Santos A, Tlili A, Mlayeh S, Bouzidi M, Ammar H, Abid S. Mnafgui K, et al. Among authors: abid s. Clin Exp Pharmacol Physiol. 2021 Jan;48(1):107-120. doi: 10.1111/1440-1681.13397. Epub 2020 Sep 28. Clin Exp Pharmacol Physiol. 2021. PMID: 32780517
Cardiopreventive capacity of a novel (E)-N'-(1-(7-methoxy-2-oxo-2H-chromen-3-yl) ethylidene)-4-methylbenzenesulfonohydrazide against isoproterenol-induced myocardial infarction by moderating biochemical, oxidative stress, and histological parameters.
Khdhiri E, Mnafgui K, Ncir M, Feriani A, Ghazouani L, Hajji R, Jallouli D, Abid M, Jamoussi K, Allouche N, Ammar H, Abid S. Khdhiri E, et al. Among authors: abid s, abid m. J Biochem Mol Toxicol. 2021 Jun;35(6):e22747. doi: 10.1002/jbt.22747. Epub 2021 Feb 23. J Biochem Mol Toxicol. 2021. PMID: 33624406
A novel synthetised sulphonylhydrazone coumarin (E)-4-methyl-N'-(1-(3-oxo-3H-benzo[f]chromen-2- yl)ethylidene)benzenesulphonohydrazide protect against isoproterenol-induced myocardial infarction in rats by attenuating oxidative damage, biological changes and electrocardiogram.
Ghazouani L, Khdhiri E, Elmufti A, Zarei A, Feriani A, Baaziz I, Hajji R, Abid M, Ammar H, Abid S, Allouche N, Mnafgui K, Ramazani A, Tlili N. Ghazouani L, et al. Among authors: abid s, abid m. Clin Exp Pharmacol Physiol. 2022 Sep;49(9):1010-1026. doi: 10.1111/1440-1681.13690. Epub 2022 Jul 24. Clin Exp Pharmacol Physiol. 2022. PMID: 35717592
454 results